Arrowhead Research | Capital Ordinaire



Ordinary Share Capital Changement Date
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Arrowhead Research USD 138.14M 137.91M 2025-06
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Ligand Pharmaceuticals USD 19.41M 19.39M 2025-06
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Novartis USD 793M 0 2024-12
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
TG Therapeutics USD 158.02M 157.87M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06
Xencor USD 71.3M 70.58M 2025-06


Arrowhead Research Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.